Announced Mon, 20 Jul · 21:08 IST
Correction: ESOP 2019 options granted revised to 5,000
Capital Market Events View source PDF
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.8%1-day move
₹516.75
prior close
₹520.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-1.4-1.7-1.6-3.8-4.8-5.2+1.0——————
Up moveDown movePending
AI summary
Rossari Biotech has issued a corrigendum to its July 18, 2026 letter on grant of options under the Rossari Employee Stock Option Plan 2019. The number of options granted was inadvertently stated as 4,000 but should now be read as 5,000 stock options, including in Annexure I. All other contents of the original letter remain unchanged. Signed by Parul Gupta, Company Secretary and Head of Legal.
Likely market impact
Minor administrative correction to ESOP grant quantity. No material change to shareholder value or stock price expected.